p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.
about
Gastric cancer: The times they are a-changin'Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsDepletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancerEffect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma.Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.Identification of hsa-miR-335 as a prognostic signature in gastric cancer.New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committeeTranscription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis.Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysisPreoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma.Targeted therapy for esophagogastric cancers: a reviewPrognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?The prognostic value of UHRF-1 and p53 in gastric cancer.C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases.An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer.Molecular markers for gastric adenocarcinoma: an update.Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasionHow do we improve outcomes for gastric cancer?Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levelsA Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumabCross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma.Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015.The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.Management of advanced gastric cancer.The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.Ramucirumab for gastric cancer.Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth.Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
P2860
Q26776195-BCDD7067-0AE3-40CB-BDBF-06F94C61AF8AQ27009534-5C4CED0D-5E97-4691-BE70-EC0C46AB67F1Q28539741-D3E86951-BDF6-43D7-BE3C-7FC9631664E4Q33269554-153047AC-4544-4C2E-856E-417BB4B146F6Q33331462-9216BAF2-118D-4690-A243-6BD3448DD2CCQ34255543-73A7C6BD-A062-416F-950B-C06CFC1B0ED7Q34339643-470896E0-AE03-4CD9-949B-C4741994BB31Q34642916-211FC4A8-8D7A-40FB-B8DB-DA00BC5C11E0Q35010828-73F19147-2D5B-4C6D-B8CD-1ADD38402BDCQ35106431-56742638-5ACC-45AA-A99D-3552E4161DD3Q35813764-5EDCE547-26A7-40F5-8F69-F4538C9ECDE7Q36039645-9198F3C1-55DB-407E-A445-E3FE669100A1Q36170610-13015893-DB4E-45AF-B9FF-3429217C7222Q36215991-1BA31324-2D27-41D1-9E6E-0ED021392A0CQ36606770-902295D4-D7E9-485F-A635-EA3B8579A4E5Q36609762-119B89E8-9CE8-4EB8-88EE-7C12B0897156Q36614306-B33E337B-9031-4E4C-B1DA-84102D68428FQ36614881-1BA7DEB8-6BB1-4660-85C8-46A74BA7E29BQ36677268-7D54BB75-3A38-42FD-A31E-171669397B6FQ36684702-15C7F3B6-6164-40A8-9E81-5A9D8C6AD8D8Q36711976-DD4C833D-0246-4BCD-91F6-E64DECEAF92AQ36816063-CAEDEF93-105D-4A9C-8586-386478C1A214Q36831149-12D2E281-6FFF-49DF-83FA-6F68E4581B3FQ36875866-6BA12B3A-11C6-4CFC-BEDE-D61E8E7340E0Q37206163-6A2AB5B0-6B7D-4470-A6B0-9DD88DB24675Q37335124-70B8C3D9-E48E-4EC2-BA5F-16AE3EB3ED1FQ37351778-423D7537-8ADC-4E77-9E16-252FB0D5A046Q37441444-6F3FD15E-9DEB-4F08-8FD1-DC9606EE94C2Q37524936-1D4CF3E5-8B48-4B8B-A640-FB6508085DC0Q37683517-816EA609-8415-4CBC-8045-12FEF67D949EQ37717519-50ED5F2F-AD2E-41F0-B876-08FF769F5376Q37989161-012924A2-D592-485B-AD0B-1D7C845BA75EQ38194507-57D54E6A-5213-42CD-9EDC-5BD79DDB922EQ38241766-51E123BA-F43E-452D-B22D-715AC575A500Q38271845-5FCE2C04-A6BF-4CAA-9001-117B801C6038Q38272318-369C991E-5501-4F34-92FF-BA477D5D45E3Q38778205-599A53D7-101A-43E3-BFBB-B5957F58652BQ39191972-49833D11-8DDE-4782-A1D5-6DA1F6389B96Q39668099-D425699E-716A-4159-8365-7C4060A508C0Q41213007-7CCA7881-0C8D-4530-A4CB-146C063F8184
P2860
p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
p53 and VEGF expression are in ...... e resection of gastric cancer.
@ast
p53 and VEGF expression are in ...... e resection of gastric cancer.
@en
type
label
p53 and VEGF expression are in ...... e resection of gastric cancer.
@ast
p53 and VEGF expression are in ...... e resection of gastric cancer.
@en
prefLabel
p53 and VEGF expression are in ...... e resection of gastric cancer.
@ast
p53 and VEGF expression are in ...... e resection of gastric cancer.
@en
P2093
P2860
P356
P1476
p53 and VEGF expression are in ...... e resection of gastric cancer.
@en
P2093
A Castells
C Fondevila
J P Metges
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601455
P407
P577
2004-01-01T00:00:00Z